CURAGEN CORP
10-K, 2000-03-07
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CURAGEN CORP, 10-K, 2000-03-07
Next: CURAGEN CORP, 10-K, 2000-03-07

EXHIBIT 11

                     

CURAGEN CORPORATION

COMPUTATION OF NET LOSS PER SHARE

ATTRIBUTABLE TO COMMON STOCKHOLDERS

 
       
       
       
                     
           
         

Year Ended December 31,


           

1997

 

1998

 

1999

           
 
 
Net loss    

($7,222,010)

 

($18,428,485)

 

($25,762,760)

Preferred dividends    

(68,424)

 

(508,435)

 

-




Net loss attributable to common stockholders    

($7,290,434)

 

($18,936,920)

 

($25,762,760)




Basic and diluted net loss per share attributable              
      to common stockholders    

$(0.92)

 

$(1.55)

 

$(1.79)




                     
Weighted average number of shares used in              
       computing basic and diluted net loss per share              
       attributable to common stockholders    
7,888,383
 

12,201,006

 

14,400,992




 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission